The Jeonnam Hwasun Microbial Validation Support Center (Director Cho Min, hereinafter referred to as the Center) announced that it successfully concluded the 'Innovation Convergence Summit – New Drug Materials and Non-clinical Validation' event held at Seoul Biohub.
This event was co-hosted with Hwasun Chonnam National University Hospital and was organized with the purpose of supporting the commercialization of innovative new drug materials. It invited experts from the entire new drug development cycle, including CDMO (contract development and manufacturing), CRO (clinical trial contract organization), and GMP consulting, targeting companies in the pharmaceutical and biotechnology fields, to review the entire development process and provide an opportunity to expand the network.
In the first part of the seminar, the center shared its plan to expand the existing public CDMO business based on the mRNA manufacturing facility scheduled to be operational in the third quarter of 2025, as well as its track record over the past six years and the differentiation and strengths of public CDMO. In addition, there were various lectures, such as the corporate support case and business introduction of Chonnam National University Hospital in Hwasun, GMP international trends by Executive Director Jaeho Jeong of BNP Care, and R&D development strategies for value-up by CEO Heesun Kim of BX Plant, which drew responses from the field.
The second networking event was attended by CDMOs, research institutes, and material, component, and equipment (SME) companies located in the metropolitan area, who discussed the possibility of developing joint businesses and provided a venue for sharing practical information through exchanges with companies located in the Seoul Bio Hub.
A center official said, “Recently, private investment such as venture capital (VC) and angel investment in the pharmaceutical and biotechnology market has been shrinking, and many new drug development pipelines are being halted,” adding, “Until the investment environment recovers, the center can provide practical support in various aspects, so we ask for your active inquiries.”
- See more related articles
You must be logged in to post a comment.